Lignocaine is one of 103 small molecule programs targeting Hemorrhoid. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
219 competitors in Cataract
Lotemax
Kenalog
Avastin
Clobetasol Propionate
Lignocaine
Aquasol E
Dexamethasone Phosphate
Mapracorat
OCS-01
Zolymbus
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details